Endometriosis is an estrogen-dependent disease. Abnormally biosynthesized estrogens in endometriotic tissues induce the growth of the lesion and worsen endometriosis-associated pelvic pain. Dienogest (DNG), a selective progesterone receptor agonist, is widely used to treat endometriosis and efficiently relieves the symptoms. However, its pharmacological action remains unknown. In this study, we elucidated the effect of DNG on enzymes involved in local estrogen metabolism in endometriosis. Surgically obtained specimens of 23 ovarian endometriomas (OE) and their homologous endometrium (EE), ten OE treated with DNG (OE w/D), and 19 normal endometria without endometriosis (NE) were analyzed. Spheroid cultures of stromal cells (SCs) were treated with DNG and progesterone. The expression of aromatase, 17β-hydroxysteroid dehydrogenase 1 (HSD17β1), HSD17β2, HSD17β7, HSD17β12, steroid sulfatase (STS), and estrogen sulfotransferase (EST) was evaluated by real-time quantitative PCR. The activity and protein level of HSD17β1 were measured with an enzyme assay using radiolabeled estrogens and immunohistochemistry respectively. OESCs showed increased expression of aromatase, HSD17β1, STS, and EST, along with decreased HSD17β2 expression, when compared with stromal cells from normal endometria without endometriosis (NESCs) (P<0.01) or stromal cells from homologous endometrium (EESCs) (P<0.01). In OESCs, DNG inhibited HSD17β1 expression and enzyme activity at 10(-7) M (P<0.01). Results of immunohistochemical analysis displayed reduced HSD17β1 staining intensity in OE w/D (P<0.05). In conclusion, DNG exerts comprehensive inhibition of abnormal estrogen production through inhibition of aromatase and HSD17β1, contributing to a therapeutic effect of DNG on endometriosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1530/JOE-15-0052 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain.
Eur J Obstet Gynecol Reprod Biol
January 2025
Department of General Surgery and Medical-Surgical Specialties, Gynaecological Clinic, School of Medicine, University of Catania, Catania, Italy.
Article Synopsis
- The study aimed to compare the pain relief effects of five different combined oral contraceptives (COCs) in women suffering from endometriosis-related chronic pelvic pain, dysmenorrhea, and dyspareunia.
- Conducted between October 2018 and March 2023, the research involved tracking pain levels using a visual analogue scale over 6 months across multiple treatment groups.
- Results indicated that COCs with estradiol (E2) or estetrol (E4) led to significantly better pain relief compared to those with ethinylestradiol (EE), and E2 or E4-containing COCs may be preferable alternatives to dienogest (DNG) for women preferring birth control.
Rapid and random-start endometrial preparation before outpatient hysteroscopic polypectomy in patients of perimenopausal age.
Climacteric
December 2024
Unit of Gynecology, Sant'Andrea Hospital, Department of Surgical and Medical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Objective: This study aimed to assess the efficacy of randomly started oral dienogest/ethinylestradiol (DNG/EE) for swift endometrial preparation prior to outpatient hysteroscopic polypectomy in perimenopausal women.
Method: A multicenter, prospective, randomized controlled trial was conducted in university hospitals. Eighty perimenopausal women scheduled for outpatient hysteroscopic polypectomy between January 2023 and March 2024 were randomly assigned to either intervention ( = 40) or control ( = 40) groups.
Divine noni's protective impact on Swiss albino mice's short-term memory impairment caused by cyclophosphamide: A behavioral and biochemical approach.
Heliyon
September 2024
Department of Pharmaceutical Chemistry, East Point College of Pharmacy, Bangalore, 560049, India.
Article Synopsis
- Cyclophosphamide (CYL) is a commonly used cancer chemotherapy drug that can lead to severe memory impairment due to its toxic effects from free radical generation.
- A study explored the protective effects of noni fruit juice (NJ), known for its antioxidant properties, against memory issues caused by CYL in Swiss albino mice.
- Results showed that while CYL treatment caused short-term memory impairment, combining NJ with CYL significantly improved memory and biochemical markers associated with oxidative stress and neuroprotection in the mice.
Objectives: To observe the therapeutic efficacy of high-intensity focused ultrasound (HIFU) combined with different pharmacological treatments for adenomyosis.
Materials And Methods: A total of 126 patients with adenomyosis who underwent HIFU combined with pharmacological treatment were retrospectively reviewed. Patients were treated with either dienogest (DNG) (Group A, = 38) or GnRH-a (Group B, = 88) for three months after HIFU, and received levonorgestrel-releasing intrauterine systems (LNG-IUS) at the end of the third month.
The clinical effect of dienogest on urinary and sexual symptoms in endometriosis patients.
J Chin Med Assoc
November 2024
Department of Obstetrics and Gynecology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
Background: To evaluate the effect of dienogest on urinary symptoms and sexual functioning within a 6-month follow-up period.
Methods: We recruited 22 women with symptoms with dysmenorrhea, deep dyspareunia, and dyschezia accompanied with irritative urinary symptoms including frequency and urgency at Kaohsiung Medical University Chung-Ho Memorial Hospital from 2017 Jan 1 to 2019 Jan 1. The diagnosis of endometriosis mainly focused on vaginal examination and transvaginal ultrasound was performed in each patient.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!